|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 15.4 TWD | -0.65% |
|
-6.38% | +1.32% |
TaiGen Biopharmaceuticals Holdings Limited reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported sales was TWD 5.76 million compared to TWD 9.68 million a year ago. Net loss was TWD 50.39 million compared to TWD 33.19 million a year ago.
Basic loss per share from continuing operations was TWD 0.07 compared to TWD 0.05 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| +1.32% | 339M | |
| -2.31% | 103B | |
| +0.56% | 95.28B | |
| +1.69% | 22.15B | |
| -17.37% | 21.02B | |
| -9.30% | 18.15B | |
| -41.01% | 16.74B | |
| -14.85% | 16.05B | |
| +3.21% | 13.68B | |
| +33.54% | 12.17B |
TAIGEN BIOPHARMACEUTICALS HOLDINGS LIMITED 
